← Back to headlines
Biogen Acquires China Rights for Immune Disease Drug in $850M Deal
Biogen has announced plans to purchase the rights to an immune disease drug for the Chinese market. The deal is valued at up to $850 million.
20 Apr, 16:04 — 20 Apr, 16:04
Sources
Showing 1 of 1 sources
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
1h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
6h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
8h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
17h ago